What it sells
We sequence your gut and build the probiotics it’s missing
Business model breakdown
Buyer: who owns the budget?
UnverifiedIndividual consumers with gut-related symptoms (B2C).
Trigger: what makes them buy now?
Probiotics that do not work and symptoms such as brain fog, mood swings and poor sleep.
Workflow: what inputs become what output?
Customer buys a microbiome shotgun DNA sequencing test, receives a made-to-order probiotic formula, then retests to confirm which strains colonized.
Economics: what it saves and how it charges
Subscription for personalized probiotics with testing bundled; retest included as proof.
Distribution: how it reaches customers
Direct-to-consumer website with scientific articles and a discovery call booking via cal.com.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Summer 2026 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.